FIU professors Angela Laird and Jorge Riera Diaz were recently inducted into the 2024 Class of the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows. Election to the ...

Jaideep Vaidya, a distinguished professor at Rutgers Business School, was recently inducted by the American Institute for Medical and Biological Engineering (AIMBE) to its College of Fellows. The ...

The Department of Chemical and Biological Engineering at Northwestern University is pioneering transformational discoveries in synthetic biology, biotechnology, catalysis, medicine, complex systems, ...

Karin Wuertz-Kozak, a faculty researcher at Rochester Institute of Technology, was recently inducted into the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.

Chemical engineer Haiqing Lin was recognized for his design, discovery and development of high-performance membrane materials for carbon dioxide capture by the American Institute of Chemical Engineers ...

The discipline of Catalysis and Reaction Engineering (CRE) seeks to control and understand the networks of reactions that occur in ‘reactors’ ranging from cellular compartments up to world-scale ...

Case Western Reserve University professor Shuo Li, PhD, has been elected a fellow of the International Academy of Medical and Biological Engineering (IAMBE), one of the highest international honors in ...

Professor Ryan Hayward has witnessed the continued advancement of the Department of Chemical and Biological Engineering since he joined CU Boulder four years ago. Now he’s looking forward to stepping ...

Distinguished Professor Kristi Anseth has received the Biomaterials Global Impact Award, which recognizes distinguished research and development accomplishments in the field of biomaterials. Anseth is ...

When Katie McKay walks across the graduation stage this May, she'll be the third McKay sibling to earn a degree from the U of A College of Engineering.

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a groundbreaking twice-yearly injectable HIV-1 capsid inhibitor for ...